This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Bachem

Profile

Bachem is a leading, innovation-driven com­pany specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further infor­mation, see www.bachem.com.

We're bringing you

  • A New Turn in Peptide Purification

    On Demand - For Members
  • Microspheres and Nanoparticles for Peptide Delivery

    On Demand - Members Only
  • Oligonucleotides @ Bachem - Interview with Torsten Wöhr

    On Demand - For Members
  • Solubility-directed Development of Trileucine Process

    On Demand - For Members
  • WHITEPAPER: Navigating the Benefits and Challenges of Microspheres and Nanoparticles for Peptide Delivery

    On Demand - For Members